Table 1 |
||||
|
Patient characteristics |
||||
|
all patients (n = 150) |
Diabetes mellitus Typ II (n = 26) |
control patients (n = 122) |
p-value |
|
|
|
||||
|
age (years) |
58 ± 5 |
57 ± 4 |
58 ± 5 |
0.1158 |
|
hypertension (%) |
62.0% |
85.00% |
57.00% |
0.0076 |
|
hypercholesterinemia (%) |
74.0% |
73.00% |
74.00% |
0.9419 |
|
hypertriglyceridemia(%) |
40.0% |
46.00% |
39.00% |
0.47068 |
|
smoking (%) |
10.0% |
4.00% |
11.00% |
0.28139 |
|
ex-smoking (%) |
75.0% |
81.00% |
74.00% |
0.4543 |
|
history of vascular diesease (%) |
31.0% |
39% |
30.00% |
0.37048 |
|
obesity (%) |
83.0% |
100% |
80.00% |
0.01134 |
|
Hyperurikämie (%) |
20.0% |
12% |
22.00% |
0.26987 |
|
total cholesterol (mg/dl) |
226 ± 42 |
225 ± 50 |
225 ± 40 |
0.5254 |
|
HDL – cholesterol (mg/dl) |
44 ± 13 |
37 ± 10 |
46 ± 14 |
0.0035 |
|
LDL – cholesterol (mg/dl) |
157 ± 39 |
159 ± 45 |
156 ± 37 |
0.9246 |
|
triglycerides (mg/dl) |
210 ± 141 |
239 ± 189 |
205 ± 130 |
0.4681 |
|
lipoprotein (a) (mg/dl) |
20,4 ± 22,5 |
16,1 ± 21,9 |
20,7 ± 22,1 |
0.1302 |
|
uric acid (mg/dl) |
6,3 ± 1,5 |
6,4 ± 1,6 |
5,6 ± 1,1 |
0.0341 |
|
fasting plasma glucose (mg/dl) |
116 ± 51 |
197 ± 75 |
100 ± 19 |
0.0001 |
|
Insuline (mU/l) |
8,8 ± 5,7 |
8,7 ± 4,7 |
8,8 ± 5,9 |
0.7382 |
|
HbA1c (%) |
6,0 ± 1,3 |
8,1 ± 1,5 |
5,5 ± 0,6 |
0.0001 |
|
heigth |
174 ± 6 |
173 ± 7 |
174 ± 6 |
0.4923 |
|
weight (kg) |
83 ± 12 |
85 ± 10 |
82 ± 12 |
0.171 |
|
Body-Mass-Index (kg/m2) |
27,35 ± 3,42 |
28,42 ± 2,78 |
27,12 ± 3,51 |
0.0367 |
|
Waist-to-Hip-Ratio |
0,99 ± 0,07 |
1,03 ± 0,07 |
0,98 ± 0,07 |
0.0035 |
|
waist circumference (cm) |
99 ± 9 |
104 ± 9 |
100 ± 6 |
0.0079 |
|
hip circumference (cm) |
100 ± 6 |
100 ± 7 |
100 ± 6 |
0.6175 |
|
|
||||
|
Jax et al. Cardiovascular Diabetology 2009 8:24 doi:10.1186/1475-2840-8-24 |
||||
